Morgan Stanley analyst Kristine Liwag lowered the firm’s price target on L3Harris Technologies (LHX) to $250 from $260 and keeps an Equal Weight rating on the shares. The company’s formal 2025 outlook calls for $21.8B-$22.2B in sales, or about 4% year-over-year organic growth, and adjusted EPS of $10.55-$10.85, the analyst noted. Management said it see opportunities in the government’s DOGE initiative, but “it is not clear to us that Primes will be ultimate beneficiaries” of government cost-cutting and restructuring efforts, the analyst tells investors.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LHX:
- L3Harris Technologies price target lowered to $265 from $300 at BofA
- Cathie Wood’s ARK Investment buys 32.7K shares of L3Harris Technologies today
- U.S. prepares new $1B arms transfer to Israel, WSJ reports
- L3Harris Highlights Record Revenue and Strategic Wins
- L3Harris Technologies Reports Strong 2024 Financial Performance